Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study

Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion

Johan T. den Dunnen, Stylianos E. Antonarakis · Human Mutation · 2000 · 1.8K citations · Full text

Complex Mutations, Genetics, Genetic Epidemiology +20

Impact of mutant p53 functional properties on<i>TP53</i>mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Audrey Petitjean, Ewy A. Mathé, Shunsuke Kato et al. · Human Mutation · 2007 · 1.6K citations · Full text

Functional Properties, Engineering, Genetics +20

Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis

Shunsuke Kato, Shuang-Yin Han, Wen Liu et al. · Proceedings of the National Academy of Sciences · 2003 · 869 citations · Full text

Engineering, Molecular Biology, Function–mutation Relationships +17

REporting recommendations for tumor MARKer prognostic studies (REMARK)

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · Breast Cancer Research and Treatment · 2006 · 801 citations

Prognostic Evaluation, Prognostic Biomarkers, Medicine +4

Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges

Sumithra J. Mandrekar, Daniel J. Sargent · Journal of Clinical Oncology · 2009 · 389 citations · Full text